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Abstract. The purpose of this study was to investigate 
variations in bone density between 16 European 
populations, 13 of which were participants in the 
European Vertebral Osteoporosis Study (EVOS). Men 
and women aged 50-80 years were recruited randomly 
from local population registers, stratified in 5-year age 
bands. The other three centres recruited similarly. 
Random samples of 20-100% of EVOS subjects were 
invited for dual-energy X-ray absorptiometry (DXA) 
densitometry of the lumbar spine and/or proximal femur 
using Hologic, Lunar or Norland pencil beam machines 
or, in one centre, a Sopha fan.-beam machine. Cross- 
calibration of the different machines was undertaken 
using the European Spine Phantom prototype (ESPp). 
Highly significant differences in mean bone density were 
demonstrated between centres, giving rise to between- 
centre SDs in bone density that were about a quarter of a 
population SD. These differences persisted when centres 
using Hologic machines and centres using Lunar 
machines were considered separately. The centres were 
ranked differently according to whether male or female 
subjects were being considered and according to site of 
measurement (L2-4, femoral neck or femoral trochan- 
ter). As expected, bone mineral density (BMD) had a 
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curvilinear relationship with age, and apparent rates of 
decrease slowed as age advanced past 50 years in both 
sexes. In the spine, not only did male BMD usually 
appear to increase with age, but there was a highly 
significant difference between centres in the age effect in 
both sexes, suggesting a variability in the impact of 
osteoarthritis between centres. Weight was consistently 
positively associated with BMD, but the ffects of height 
and armspan were less consistent. Logmithmic trans- 
formation was needed to normalize the regressions of 
BMD on the independent variates, and after trans- 
formation, all sites except he femoral neck in females 
showed significant increases in SD with age. Interest- 
ingly, the effect of increasing weight was to decrease 
dispersion in proximal femur measurements in both 
sexes, further accentuating the tendency in women for 
low body mass index to be associated with osteoporosis 
as defined by densitometry. It is concluded that there are 
major differences between BMD values in European 
population samples which, with variations in anthro~ 
pometric variables, have the potential to contribute 
substantially to variations in rates of osteoporotic 
fracture risk in Europe. 
Keywords: Aging; Bone densitometry; Epidemiology; 
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Introduction 
In Europe, there are great geographic variations in rates 
of osteoporotic fracture. The MEDOS study, a case- 
control study of hip fracture in southern Europe, 
demonstrated rates that in some age groups varied 
geographically by more than an order of magnitude [1]. 
Also, we have recently shown in the European Vertebral 
Osteoporosis (EVOS) study that vertebral deformities 
vary over a 3-fold range in both sexes [2,3]. EVOS was a 
prevalence study of 17342 male and female subjects 
drawn randomly from local populations registers. All 
were between 50 and 80 years of age and each 
population sample was age stratified. 
Of the 36 participating EVOS centres, 13 took the 
opportunity to make bone mineral density (BMD) 
measurements of the spine and/or hip region using 
dual-energy X-ray absorptiometry (DXA) equipment. 
An additional three centres joined the present study 
because they had used identical principles to recruit heir 
subjects, although they did not take lateral spine X-ray 
films at he same time. An important objective of doing 
this was to see whether BMD varied between popula- 
tions and, if so, whether these variations were sufficient 
in scale and direction to account for a proportion at least 
of fracture rate variation in Europe. Because the EVOS 
centres have used densitometers made by different 
manufacturers, it was important first to cross-calibrate 
the measurements obtained. An approach to doing this 
using the Et~opean Spine Phantom (ESP) and its 
predecessor the ESP prototype (ESPp) has recently 
been published [4-6]. We have found substantial 
differences in BMD between populations that cannot 
be accounted for by variations in height, weight or 
selection bias. 
Materials and Methods 
Populations 
Sixteen centres in 12 countries took part in the study 
(Table 1), 13 of them being centres participating in 
EVOS. In EVOS each centre used a population-based 
register from their locality to select a population-based 
random sample of up to 600 subjects. As previously 
described, each sample was stratified equally by sex and 
age into six 5-year age bands (50-54, 55-59, 60-64, 65- 
69, 7074,  75-80) and the mean response rate was 54% 
in EVOS as a whole and 60% in the 13 EVOS centres 
represented in this study [2,3]. In each of these 13 EVOS 
centres, random subsamples of between 20% and 100% 
of recruited subjects were invited for bone densitometry. 
In Harrow, the subsample was a true random sample of 
the main sample, while in the other centres attempts 
were also made to ensure that he densitometry 
subsample was free of selection bias. The subjects 
from Cambridge [7] and Malm6 [8] were drawn 
randomly from the subjects measured in these non- 
EVOS studies according to the same principles used in 
M. Lunt et al. 
Table 1. Densitometer brand and numbers of subjects from each 
centre 
Densitometer Centre Sex 
brand 
Male Female All 
Hologic Berlin 194 I76 370 
Heidelberg 106 85 191 
Harrow 35 36 71 
Moscow 72 111 183 
Oviedo 230 256 486 
Cambridge 155 276 431 
Lunar Leuven 131 190 321 
Rotterdam 240 242 482 
Manchester 24 50 74 
Oslo 146 158 304 
Malm6 84 95 179 
Erfurt 96 122 218 
Sopha Graz 266 248 514 
Norland Budapest 165 196 361 
Aberdeen 260 257 517 
Piestany 24 83 t 07 
All 2228 2581 4809 
EVOS. Manchester ecruited for their COMAC-BME 
centre [4,6] according to the principles used in EVOS as 
outlined above. All centres performed ensitometry of 
the lumbar spine, and 14 centres performed ensitometry 
of the hip. Altogether, 4774 complete records on the 
spine were received (2555 women) and 3826 records on 
the hip (2089 women). The number of subjects per 
centre varied from 71 to 517, with a median of 313. In 
the 13 EVOS centres, all participating subjects had a 
lateral radiograph, which was evaluated in Berlin for the 
presence of one or more vertebral deformities. 
DXA and Cross-Calibration 
The densitometers in each centre were cross-calibrated 
using the ESPp. In previous work we found that the L2- 
4 region of the spine [6] as well as the femoral neck and 
trochanter [4] could be satisfactorily cross-calibrated for 
Hologic, Lunar and Norland pencil beam machines. 
Appendix A gives our method for cross-calibrating the 
Sopha machine in this study. The ESPp is a semi- 
anthropomorphic phantom with three "vertebrae" of 
specified ensities: 0.5 g/cm 2, 1 g/cm 2 and 1.5 g/cm ~. At 
least five measurements of the phantom were made on 
each machine and a two-parameter xponential model 
fitted: 
y = ~(1 -- e -~x) (1) 
where y is measured ensity and x is specified ensity, as 
described by Pearson et al. [5]. All bone density 
measurements were then converted to standardized 
densities using Eq. (1) rearranged as in Eq. (2) and 
using the values of a and b specific to the centre's 
densitometer: 
Variations in DXA Bone Density in Europe: The EVOS Study 
Standardized density - 
- l og  (1 - 5) 
DXA Quality Control 
(2) 
All centres participated in one or both of the following 
EU Concerted Actions: "Quantitative Assessment of 
Osteoporosis" (COMAC-BME, Project Coordinator J.
Dequeker) and EVOS (Project Coordinator A. J. 
Silman). Each Concerted Action organized annual 
meetings at which principles and procedures for 
performing densitometry and densitometric analyses 
according to the manufacturer's instructions were 
agreed and monitored. Quality control in densitometry 
was enhanced by regular visits to centres by members of 
the two project management groups and periodic review 
of specimen analyses. Also, outlier values were 
identified, queried and, if appropriate, re-analysed by 
the centres. Day-to-day quality control was managed by 
the centres, which ensured machine stability by 
performing calibrations with their machine-specific 
phantoms daily or every other day. Patient positioning 
was carried out using the instructions and accessories of
the manufacturers. All Lunar centres rigorously excluded 
the small numbers of scans in which air had inadver- 
tently been scanned by inadequate "bolusing" of the hip 
region. The principal residual scope for between-centre 
systematic differences lay in possibly different ap- 
proaches to editing of lateral spine edges. This editing 
process was therefore proscribed by agreement between 
all centres o as to minimize between-centre variation in 
technique. 
Statistics 
The dependent variables investigated were the means 
and variances of the standardized bone densities for each 
of the three measured sites: spine, femoral neck and 
femoral trochanter. For each dependent variable the aims 
were: (i) to see how it varied with age, height, weight 
and centre; (ii) to test for significant differences between 
centres; (iii) to test whether the effects of age, height and 
weight differed between the different centres. 
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Means. ANOVA was used to test for differences 
between centres in crude means, for each sex separately. 
The correlation between bone density at the three 
different sites was measured in each centre, and 
differences between centres in tile relationships between 
densities at different sites tested using linear regression, 
including centre as a covariate. 
To investigate the effects of age, height and weight 
on bone density, first a "comprehensive" model was 
established, fitting bone density to age, height, weight, 
measurement centre and all interactions of age, height 
and weight with centre. To allow for possible non- 
linearity in the relationship between age and bone 
density, age 2 and its interaction with centre were also 
fitted. In preliminary testing it was established that 
there was no measureable non-linearity in the relation- 
ships between bone density and any of the other 
variables. As the normality of the residuals improved 
after log-transformation, all subsequent analyses were 
based on the log of bone density. After transformation 
there was a very small number of outliers (< 3 per sex 
per site), which were not excluded from the analysis 
since they did not affect he parameter estimates. Then 
a backwards tep-wise approach was used to remove 
variables from the model that were not significant 
predictors (at p = 0.05). Where a p value is quoted for 
an effect it represents the p value in the final model, or 
the p value in the last model before it was removed. 
Separate final models for each sex and site were 
produced. 
There was evidence that the variance in bone density 
increased with age, contrary to the assumptions of 
normal errors multiple regression. If uncorrected, this 
would lead to inaccurate hypothesis tests for between- 
centre comparisons. An iteratively reweighted least 
squares (IRLS) method ue to Aitkin [9] was therefore 
used to correct for this, implemented asan SAS macro 
[10]. This method will also correct for any possible 
difference in variance between centres. 
The variances due to differences between centres were 
each assumed to be the sums of two components in each 
case: variance between manufacturer's brands and 
remaining variance between centres. These components 
were compared using an F-test to see whether the 
differences between brands were greater than would be 
expected given the observed differences between 
centres. 
To test whether adjusting for age, height and weight 
reduced the differences in means between centres, the 
variance of the unadjusted centre means was compared 
with the variance of the centre means adjusted to age 65 
years, height 1.65 m and weight 70 kg, using Pitman's 
test [11] for correlated variances. 
Based on a study of a West African population, 
Asprey et al. [12] found a significant relationship 
between the ratio of sitting to standing height and 
BMD measurements in the spine or femoral neck. 
Although none of our centres measured sitting height, 12 
of the 16 centres measured armspan. It seemed reason- 
able to use armspan as a means of investigating the 
possible relationship between body proportions and 
BMD in Europeans, since armspan and leg length are 
strongly correlated and leg length as a proportion of total 
height is complementary to sitting height. Therefore, 
having completed the modelling described above, the 
effect of armspan was investigated by taking the bone 
density model derived from all 16 centres and adding in 
armspan and height separately as independent variables 
in modelling the data from the 12 centres, and finally 
adding in both together. 
Standard Deviations. Differences between c tres in the 
standard eviation of the distribution of bone density 
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could not be tested for directly, since the distributions 
were not normal, and testing for differences in standard 
deviation requires normality. A log-transformation 
would have normalized the data, but the variance of 
the transformed ata in each centre would then have 
depended on the mean value in that centre, which would 
affect any test of differences in variance. To avoid this 
problem, the appropriate centre- and sex-specific mean 
value was subtracted from each measurement sothat the 
mean value in each centre became 0. A constant was 
then added to each term to ensure that all values were 
positive, then the data were log transformed. These 
"residuals" could then be tested for differences in 
standard eviation (strictly differences in variance, the 
square of the standard deviation) using Bartlett's test 
[11]. 
To test whether there were significant between-centre 
differences in standard deviation after adjusting bone 
density for age, height and weight, the residuals from the 
final regression model were used. Bartlett's test could be 
applied to these directly, since they were already 
normally distributed. 
There were considerable differences in the numbers of 
subjects from each centre. This would not bias the 
results, provided there was no bias in the selection of 
subjects, since ntres with few subjects will have less 
effect on the regression model than centres with many 
subjects. However, in a given centre, if subjects with low 
bone density were more or less likely to be measured 
than subjects with high bone density, this would affect 
the estimate of mean bone density in that centre. It" any 
demonstrable selection bias differed between centres, 
this could create apparent differences between centres 
when the true mean bone density was the same. If the 
relative risk of subjects with low bone density attending 
for densitometry varied with age then the regression 
coefficients for the effect of age on bone density would 
be biased. If this effect differed between centres, it 
would explain differences in apparent rates of bone loss 
between centres. 
It is not possible to test directly whether such selection 
bias did occur, since we do not know the bone density of 
the subjects who were not measured. However, all 
EVOS subjects underwent a lateral spinal radiograph. 
These were evaluated quantitatively in Berlin for the 
presence of vertebral deformities. We used these 
deformity data as surrogate measures, assuming that 
subjects with deformities were more likely to have low 
bone density [13]. The relative risk of receiving 
densitometry in subjects with vertebral deformities 
compared with subjects without deformities was 
calculated using the Mantel Haenszel method, to assess 
the overall selection bias. To test for differences between 
centres in the relative risk, the Breslow-Day test [14] for 
homogeneity for the odds ratios was used. Logistic 
regression was used to determine whether the probability 
of subjects with low bone density attending for 
densitometry varied with age, and whether this effect 
differed between centres. 
Results 
Mean Bone Density Values 
There were highly significant differences between 
centres in mean bone density. Adjusting for age, height 
and weight had very little impact on these differences; 
the significance level of the differences did not change 
greatly (p< 10 -4 for all sites, for both sexes, before and 
after adjustment) and the between-centre variance was 
not significantly reduced (p >0.15 for all sites and both 
sexes). The between-centre standard deviation was 
approximately one-quarter of the between-subject 
standard deviation, i.e. the difference in mean bone 
density between the highest and lowest centres was 
about 1 population SD (Tables 2, 3). Figure 1 shows the 
mean values at each centre for all three measurements 
sites adjusted for weight and age. Figure 2 shows 
individual data from the trochanter and spine to illustrate 
the effects of centre-related differences in relation to age. 
Table 2. Means and standard eviations of standardized, crude bone 
density values lor both sexes in 16 European centres (results 
expressed in g/cm 2) 
Centre Spinal bone Trochanteric Femoral neck 
density bone density bone density 
Mean SD Mean SD Mean SD 
~romen 
Aberdeen 0.9585 0.1911 0.6820 0.1292 0.8038 0.1386 
Berlin 1.0670 0.2367 0.7070 0.1240 0.8317 0.1555 
Budapest 0.9349 0.1599 0.7068 0.1189 0.8286 0.1245 
Erfurt 1.0023 0.2299 
Graz 0.9624 0.2252 
Harrow 1.0637 0.2592 0.6944 0.1516 0.8117 0.1774 
Heidelberg 1.0934 0.2489 0.6988 0.1554 0.7921 0.1486 
Cambridge 1.0844 0.2406 0.6701 0.1285 0.7506 0.t422 
Leuven 1.0000 0.2118 0.6882 0.1432 0.7698 0.1421 
Malm6 0.9396 0.1836 0.6500 0.1462 0.7304 0.1519 
Manchester 1.0327 0.2015 0.6928 0.1168 0.7938 0.1187 
Moscow 1.0489 0.2335 0.6812 0.1229 0.8045 0.1624 
Oslo 0.9364 0.1852 0.6463 0.1385 0.7235 0.1348 
Oviedo 0.9585 0.2152 0.6070 0.1042 0.7347 0.1306 
Piestany 0.9396 0.1509 0.6860 0.1062 0.8132 0.1123 
Rotterdam 0.9790 0.1932 0.6733 0.1330 0.7667 0.1273 
Men 
Aberdeen 1.1419 0.2026 0.8898 0.1268 0.9134 0.1358 
Berlin 1.t739 0.2126 0.8239 0.1400 0.9033 0.1437 
Budapest 1.0473 0.1688 0.8431 0.1096 0.9094 0.1129 
Erfurt 1.1048 0.1857 
Graz t.1000 0.2465 
Harrow 1.2337 0.2429 0.8361 0.1417 0.9123 0.1767 
Heidelberg 1.2621 0.3082 0.8506 0.1471 0.9252 0.1792 
Cambridge 1.2128 0.2780 0.7920 0.1547 0.8296 0.1591 
Leuven 1.1098 0.2138 0.8329 0.1565 0.8620 0.1584 
Malm6 1.1179 0.2059 0.8497 0.1589 0.8653 0.1397 
Manchester 1.1680 0.1920 0.8504 0.1210 0.8942 0.1439 
Moscow 1.1880 0.2478 0.7775 0.1340 0.8940 0.1486 
Oslo t.0660 0.1974 0.8237 0.1412 0.8589 0.1245 
Oviedo 1.1525 0.2424 0.7700 0.1369 0.8831 0.1656 
Piestany 1.1433 0.2012 0.8517 0.1245 0.9179 0.1044 
Rotterdam 1.1379 0.2200 0.8161 0.1388 0.8520 0.1307 
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Table 3. Comparison of unadjusted with adjusted a mean standardized bone density values (results expressed in g/cm 2) and the effect of 
adjustment on population a d between-centre standard deviations 
Men Women 
Spine Trochamer Femoral Spine Trochanter Femoral 
neck neck 
Mean bone density 
Crude 1.138 0.827 
Adjusted 1.056 0.784 
Population SD 
Crude 0.2318 0.1426 
Residual 0.2204 0.1334 
Between-centre SD 
Crude centre means 0.0582 0.0323 
Adjusted centre means 0.0566 0.0309 
Crude between-centre SD/crude population SD 25% 23% 
Adjusted between-centre SD/residual SD 26% 23% 
0.885 0.993 0.674 0.780 
0.842 0.959 0.661 0.761 
0.1485 0.2t69 0.1309 0.1430 
0.1355 0.1926 0.1068 0.1194 
0.0291 0.0570 0.0366 0.0273 
0.0357 0.0507 0.0244 0.0286 
20% 26% 28% 19% 
26% 26% 23% 24% 
aAdjusted to age 65 years, weight 70kg, height 1.65 m. 
Effect of Machine Brand. After cross-calibration there 
were still differences in mean bone density between 
densitometers of different brands, at the femoral neck 
and spine in both sexes. The mean bone density at each 
site, after adjusting for age, height and weight, for each 
brand of densitometer is given in Table 4. The 
differences between centres after adjusting for instru- 
ment brand (which makes the assumption that there is no 
true difference between populations means used by 
different brands of densitometer) remained highly 
significant (p<10 -2 at the femoral neck in men; 
p<10 -3 at all other sites). As Table 4 shows, there 
were significant differences between centres using the 
same brand of densitometer when all three brands of 
densitometer were considered separately, showing that 
the between-centre differences are not due to inadequate 
cross-calibration between brands. 
Effects of Other Variables 
The final :regression models for all sites and both sexes 
for the bone density means and variances are given as 
algebraic equations in Appendices B and C. The 
statistical significance of the various differences between 
centres are summarized in Table 5. Appendices B and C 
give regression equations for each sex and BMD site, by 
centre, with age, age 2, weight and height as the 
independent variates. The effects that were common to 
all centres are given below. 
Effect of Age. For women, there was considerable 
curvature in the relationship between age and bone 
density at all three sites (/)<0.002), with the rate of 
decrease of bone density tending to decrease with age. 
At the femoral neck, relationships with age were similar 
in each centre: on average bone density decreased by 
1.23% per year at age 55 years, 0.77% per year at age 65 
years, and by 0.31% per year at age 75 years. At the 
spine and trochanter, the rate of bone loss at age 65 years 
varied between centres (see Appendix B, Tables B 1 and 
B2 for details). 
In men, the effects of age was less strong than in 
women. At the femoral neck and trochanter there was no 
evidence of differences between centres with age in rates 
of change or in curvature (p > 0.2). Bone density did not 
change significantly with age at the trochanter (estimate 
0.08% per year; 95% CI: -0 .16%, 0.01%) and 
decreased at a constant rate of 0.25% per year at the 
femoral neck (95% CI: 0.16%, 0.34%). 
At the spine in men, there was evidence of differences 
between centres in rate of change at age 65 years 
(p = 0.03), but the curvature in the relationship of density 
with age was slight and similar between centres. Bone 
density decreased significantly with age in one centre 
(Leuven), increased significantly in seven centres, and 
was not significantly different from zero in seven centres 
(Appendix B, Tables B4-B6). 
Effect of Weight. In men, the effect of weight on bone 
density was consistent between sites and centres. Bone 
density- increased by 0.52% for every kilogram increase 
in weight at the spine, 0.53% per kg at the trochanter, 
and by 0.51% for every kilogram increase at the femoral 
neck. In females, femoral neck bone density increased by 
0.57% for every kilogram in all centres, but the effect of 
weight on bone density differed between centres at the 
spine and trochanter over 2- to 3-fold range (Appendix 
B, Tables B1 and B2). 
Effect of" Height. In men, height ad no consistent effect 
on bone density at any site. The effect appeared to differ 
between centres at the femoral neck (p = 0.008), clue to a 
large positive effect in one centre (Manchester, density 
increased by 0.83% per cm) and a negative ffect in one 
other centre (Rotterdam, density decreased by 0.43% per 
cm). 
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In women there was no relationship between height 
and bone density at the trochanter or femoral neck 
(p = 0.23, 0.4 respectively). At the spine, bone density 
increased by 0.16% for each centimetre increase in 
height, with no apparent differences between centres. 
Effect of' Armspan. In men from the centres that 
measured armspan, bone density increased slightly 
with increasing height (0.14% per cm) but was not 
associated with axmspan (decrease of 0.07% per cm, 
p = 0.26). However, when both armspan and height were 
included in the model, the association between height 
and bone density was stronger (increasing by 0.38% per 
cm) and armspan also became significant (decrease of 
0.29% per cm, p<0.0008).  In women from these 
centres, spine bone density was significantly associated 
with height (increase of 0.21% per cm) but not with 
armspan (p = 0.19). However, when both height and 
armspan were included, armspan remained non-signifi- 
cant (p = 0.19), while the effect of height increased 
slightly (increase of 0.30% per cm). 
Trochanteric bone density decreased with increasing 
armspan in men. Bone density decreased by 0.19% per 
cm increase in armspan without adjusting for height, or 
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Fig. 2. Unadjusted individual results for trochanteric bone density in women (n) and spinal bone density in men (b), highlighting the results from 
the centres with the highest and lowest mean bone density. The regressions of bone density versus age for these highest and lowest centres are also 
shown. 
0.24% with height adjustment, although eight was not 
associated with bone density whether o not armspan 
was included in the model (p >0.1). Neither height nor 
armspan had an association that was statistically 
significant with femoral neck bone density in either 
sex, nor at the trochanter in women (p>0.14). 
Between-Site Correlations. There were, as expected, 
relationships between the bone density at the femoral 
neck and the bone density at the trochanter ( = 0.79 in 
4 men, 0.79 in women, p<10-  in both sexes). In 
addition, there were significant differences between 
centres in this relationship: allowing for between- 
centre differences increased the proportion of the 
variance in femoral neck bone density expiained from 
62% to 66% in men (p< 10-4), and from 63% to 66% in 
women (p = 0.001). The relationship between bone 
density at the spine and at the trochanter was less strong 
(R=0.57 in men, 0.63 in women; p<10 -4 in both 
sexes). Again, the relationship varied significantly 
between centres: allowing for between-centre differ- 
ences increased the proportion of the variance in spine 
bone density explained from 32% to 41% in men 
(p < 10-4), and from 40% to 49% in women (p < 10-4). 
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Table 4. Mean adjusted, standardized bonedensity by densitometer brand and significance ofbetween-brand differences 
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Mean bone densities Significance ofbetween-centre differences 
Spine Femoral Trochanter Spine Femoral Trochanter 
neck neck 
Men 
Mean bone densities 
Hologic 1.186 0.873 0.795 0.03 0.01 0.002 
Lunar 1.096 0.841 0.816 0.002 0.12 0.087 
Norland 1.094 0.916 0.848 0.000t 0.47 0.0001 
Sopha 1.074 
Signicance of differences between brands 0.025 0.048 0.099 
Women 
Mean bone densities 
Hologic 1.027 0.770 0.663 0.0001 0.0001 0.0002 
Lunar 0.959 0.753 0.669 0.74 0.040 0.81 
Norland 0.928 0.799 0.673 0.01 0.39 0.0l 8 
Sopha 0.942 
Signicance of differences between brands 0.013 0.059 0.85 
Table 5. Table of significance of differences between centres (probability values p tested against the null hypothesis) after adiusting for 
densitometer brand 
Mean densities Women Men 
Spine Trochanter Femoral Spine Trochanter Femoral 
neck neck 
Stanardized toage 65 years <0.0001 0.0001 
Rate of change with age at 65 years 0.02 0.51 
Curvature inrate of change with age 0.77 0.005 
Effect of weight 0.05 < 0.0001 
Effect of height 0.33 0.59 
<0.0001 <0.0001 <0.0001 0.001 
0.46 0.03 0.40 0.23 
0.89 0.23 0.72 0.46 
0.09 0.56 0.56 0.24 
0.46 0.40 0.16 0.008 
Potential Selection Bias 
In women, there was no evidence that the subjects 
without vertebral deformities were more likely to receive 
bone densitometry (relative risk 1.05; 95% CI: 0.98, 
1.12), nor of differences between centres (p = 0.14). In 
both Budapest and Heidelberg, women with deformities 
were less likely to have had densitometry, and so the 
mean bone densities of the populations in these centres 
could possibly be overestimated. However, Table 2 
shows that Budapest has the lowest spinal bone density, 
although it has comparatively high hip bone density. 
Heidelberg ranked quite highly for both spine and 
trochanter, although not for femoral neck. 
Older women were less likely to attend for bone 
densitometry than younger women, so any analyses need 
to be adjusted for age. However, there was no evidence 
that the probability that a subject with a deformity 
receiving bone densitmetry was affected by age overall 
(p = 0.7), nor that such an effect differed between centres 
(p = 0.12), so the estimates of the effect of age on bone 
density should be reliable. 
In men, there was no evidence of selection bias overall 
(relative risk 1.05; 95% CI: 0.98, 1.13); however, there 
was a suggestion of differences between centres 
(/)=0.08). There were significant effects in Moscow 
and Oslo, where men with deformities were less likely to 
have had densitometry, and so the mean bone densities 
of these samples can be expected to be an overestimate 
of the mean bone densities in the relevant populations. 
However, Table 2 shows that neither of these centres has 
particularly high bone densities, Oslo being a centre with 
one of the lowest bone densities. Other than in these two 
centres, there is no evidence of selection bias either 
overall or differing between centres. Thus the observed 
differences in mean bone density between centres cannot 
be explained by selection bias. 
In men, it appeared there were differences between 
centres in the association between age and the 
probability that a subject received densitometry 
(p =0.02). However, this effect could be isolated to a 
single centre (Erfurt) where older subjects with 
deformities were more likely to be measured than 
younger subjects with deformities, so the rate of bone 
loss in this centre may be overestimated. However, only 
the spine was measured in this centre and Table B4 
shows that while this centre showed a slower increase 
with age than most other centres, there were two centres 
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that showed an actual decrease in bone density with age. 
Other than at his centre, there 'was no evidence that the 
probability of a subject with a deformity receiving bone 
densitometry was affected by age overall (p = 0.4), nor 
that such an effect differed between centres (p = 0.21). 
Standard Deviation (SD) 
increase at the trochanter. The combined effects of 
weight on bone density and bone density SD in two 
populations of women - those with respectively the 
highest and lowest mean femoral neck adjusted bone 
density values - are illustrated in Fig. 3. This shows the 
prevalence of bone density values below a cut-off of 2.5 
SDs below the mean young normal value reported in a 
mixed European population by Pearson et al. [4]. 
The SDs of the transformed ensities differed signifi- 
cantly between centres, both before and after adjustment 
for height (which did not appear to affect the SD) and 
weight. In Appendix C, Tables C 1-C6 give the SD of the 
bone density in each centre at each site for each sex, 
adjusted to age 65 years and weight 70 kg. 
Effect of Age. In men, the SD of the bone density 
increased with increasing age by 0.77% for each 
additional year at the spine (95% CI: 0.41%, 1.14%), 
0.48% at the trochanter (95% CI: 0.07%, 0.89%), and 
0.57% at the femoral neck (95% CI 0.17%, 0.98%). This 
effect did not appear to differ between centres. 
In women, age did not appear to affect he SD of bone 
density at the femoral neck. However, the SD increased 
with each year of age by 1.18% at the spine (95% CI: 
0.84%, 1.52%), and by 0.55% at the trochanter (95% CI: 
0.17%, 0.93%). 
Effect of Weight. In women, the SD of hip bone density 
was inversely related to weight, decreasing as weight 
increased. The decreases were v ry similar at the neck 
and trochanter: -0.38% (-0.65%, -0.12%) per 
kilogram weight increase at the femoral neck and 
--0.44% (--0.70%, --0.17%) per kilogram weight 
0,4C 
o.3c 
Oviedo 
Harrow 
0.2C 
O.lO 
0.00 
Weight = 50 kg Weight = 60kg Weight = 70 kg 
Fig. 3. Predicted prevalence of femaIe femoral neck bone density 
values below 0.580 g/cm 2 after adjustment toage 65 years according 
to our statistical model. This is the value presented by Pearson et al. 
[4] for a mixed population of normal young European women to 
represent a T-score of --2.5 as defined by Kanis et al. [34]. For 
illustrative purposes, women are considered from our two centres with 
the highest (Harrow) and lowest (Oviedo) mean age- and weight- 
adjusted BMD values in the femoral neck; both these centres used 
Hologic machines. The predicted prevalences among women of 50 kg, 
60 kg and 70 kg body weight are shown to demonstrate the association 
of low bone density with low body weight. 
Discussion 
These results have demonstrated clear differences 
between European populations in bone density at all 
three sites measured. These are evident between centres 
using the same brand of densitometer and persisted after 
cross-calibration and additional statistical adjustments 
for machine brand, so cannot be considered possible 
artefacts due to cross-calibration errors. Variations in 
body size have also been documented but these explain 
only a small part of the differences in bone density. 
CompmSson of our data with those obtained in a multi- 
centre study performed in the continental USA suggests 
that on a geographical basis bone density variation in 
Caucasians i several-fold larger in Europe than in North 
America [15]. In fact, for the female femoral neck data, 
the mean difference between Oviedo (the lowest) and 
Harrow (the highest) suggests a difference in future hip 
fracture risk of 2.5- to 3.0-fold based on the relationship 
established by Cummings et aI. [16] (Incidentally, both 
of these centres used Hologic densitometers.) The results 
presented in this paper offer no explanation for the 
observed variations in bone density. It is likely that these 
are the results of interactions between genetic and 
environmental factors. 
Previous studies comparing Caucasian populations 
with those of other ethnic origins have found substantial 
between-group differences in BMD [17-21], but this is 
the first study which has shown in true population 
samples substantial differences in BMD between 
different Caucasian populations, after adjusting for 
body size. 
Since our early publications on the ESPp [4--6], it has 
now been established that this is not a perfect instrument 
for cross-calibrating different manufacturers' brands of 
bone densitometer. In particular, since the development 
of an improved ESP [6,22] it has now become clear that 
use of the ESPp leads to modest overestimates of 
standardized values measured in the spine by Hologic 
machines. This is probably the indirect result of 
underestimates of the bone density by Hologic machines 
when measuring the 1.5 gm/cm 2"vertebra" in the ESPp 
by comparison with the definitive version of the ESP. 
Realizing this problem, we applied a statistical approach 
to adjust for potential systematic errors in cross- 
calibration. 
Possibly because of the size of the populations studied 
or because of the recruitment method whereby subjects 
were not excluded who might have been excluded from 
other so-called normal series, we have identified certain 
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statitical characteristics of our data which have only 
been noted inconsistently in the previous literature. The 
trend towards log-normality of data distribution is 
noteworthy. This confirms observations made in the 
previous COMAC-BME study for the majority of sites 
measured in the DXA data series [4,6]. The change in 
variance with age is another notable aspect of our results. 
With respect to the spine measurements i  eems possible 
that this could relate to the impact of spinal osteoarthritis 
as noted previously by Masud et al. [23] and Burger et 
al. [24]. The differences between centres in trends with 
age and the effect of age on variance were previously 
commented on in the COMAC-BME study, but that 
study was not consistent in the recruitment method used. 
The present study, which is considerably larger, has 
established that both characteristics of European multi- 
centre DXA data are intrinsic to the populations rather 
than the result of methodological inconsistency. The 
COMAC-BME centres which based their recruitment on 
random samples of their local populations have also 
joined the present study, so some of the present data 
from Berlin, Harrow, Leuven, Manchester and (with a 
50% sample) Aberdeen have also been included in the 
two relevant COMAC-BME publications [4,6]. For 
logistic and financial reasons, it was not possible to 
attempt to recruit population samples that were 
representative of the national populations from which 
the subjects came. Therefore, our samples are repre- 
sentative of their local populations, not necessarily of 
their national populations. 
These measurements were all performed at the 
beginning of a prospective study of osteoporotic fracture 
based on normal European populations [25] - now 
known as the European Prospective Osteoporosis Study. 
Currently it is not known whether variations in bone 
density in these populations will translate into similar 
variations in incident fractures. In previous single- 
country European [26,27] and North American 
[16,28,29] studies, bone density has been shown to be 
predictive of fracture in age groups ranging over the 
spread of ages studied in the populations represented in 
this paper. However, components of fracture risk not 
attributable to bone density have been identified by Ross 
et al. [30,31] and others in patients who have suffered a 
previous osteoporotic fracture. It has now been shown in 
several studies that the existence of a prevalent fracture 
is a risk factor for a further osteoporotic fracture at the 
same or another site, which at any given level of bone 
density is significantly higher than for controls matched 
for bone density but not having suffered a previous 
(prevalent) deformity [30,31]. Vertebral dimensions also 
contribute to risk [32]. It is therefore plausible that 
variations in bone density in Europe will not translate 
into comparable variations in fracture incidence because 
of other elements of fracture risk which are not captured 
by DXA measurements. Before substantial resources are 
directed towards using bone density measurements a
surrogates for risk measurement which canbe exported 
between communities, further work needs to be done to 
compare relationships in different communities between 
bone density and fractures. For example, we already 
know that fracture rates in some African countries 
[21,33] and among the Maoris of New Zealand [20] may 
not be entirely explained by the risk models based on 
relationships observed between BMD and fracture risk in 
Caucasian populations. 
In previous epidemiological work in Europe, hip 
fracture risk has been shown to have a high degree of 
geographic variability in the MEDOS study, with the 
oldest cohorts in the least-affected centre having a 13- 
fold lower risk than comparable cohorts in the most- 
affected centre [1]. It seems unlikely from the data 
presented that such a spread on fracture risk could be 
accounted for solely by bone density on relationships 
previously published between incident fracture rates and 
bone density levels. However, the 3-fold variation in 
vertebral deformity prevalence reported by O'Neill et al. 
[3] is within the range that might be explained by bone 
density variation in Europe. 
For the management of female patients at risk of 
osteoporosis, the WHO [34] has recently suggested that 
for those under 75 years their bone density should be 
assessed in relation to the distribution of values obtained 
in young normal subjects. Our results raise several 
questions in relation to this proposal. The first is whether 
young normal subjects from different European com- 
munities will show the same variation in bone density as 
obtained in our subjects over the age of 50 years. If this 
is the case the question then arises whether risk 
assessment should be related to young normal values 
obtained in the local community or to some composite 
normal value obtained by pooling results from many 
communities. This in turn reflects back on the question 
of whether absolute values of bone density in Europe are 
more closely related to risk of incident fractures than 
some locally derived index of deviation from the young 
normal standard. The collection of adequate amounts of 
young normal data to provided local standards for risk 
assessment will be a daunting task in some countries, 
because the precise definition of standard eviation in 
terms of a defined level of methodological precision 
requires larger numbers than the definition of mean 
values to the equivalent level of precision. There is also 
the problem with young subjects of ensuring representa- 
tive sampling because of high refusal rates among 
recruits experienced in many countries when representa- 
tive samples are sought based on the population 
registers. 
In conclusion, our study has demonstrated substantial 
variations between European populations in mean bone 
density, the variance of bone density and rates of change 
with age in populations. These variations are not 
explained by differences in body size and may have 
considerable implications for explaining variations i  
fracture rate already documented across Europe. Our 
results are also relevant to implementing the recommen- 
dations of the WHO for using bone densitometry in 
fracture risk assessment in patients. We conclude that it 
is important to document the relationship between risk of 
incident fractures and bone density in the populations we 
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have studied. The EVOS prevalence study has now 
become the European Prospective Osteoporosis Study 
(EPOS) of incident fractures, which has been in progress 
for 3 years and is still continuing. We are therefore 
enlarging our database of DXA measurements per- 
formed in the centres contributing to EPOS with an 
additional 10 or more centres planning to perform bone 
densitometry for use in prospective risk assessment. 
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Appendices 
Appendix A. Cross-Calibration of the Sopha SRA 
Fan-Beam Densitometer (Graz) 
The Sopha SRA fan-beam densitometer was supplied by 
the manufacturer with an aluminium alloy phantom cut 
out of sheet metal as well as a Perspex "water- 
equivalent" block on the top of which this manufac- 
turer's phantom is scanned for daily quality control. This 
block was exactly the same height as the ESPp. After 
early attempts to scan the ESPp had failed, due to the 
densitometer's software failing to define the edges of the 
three ESP "vertebrae", it was found that this problem 
was easily rectified by scanning the Perspex block 
without the manufacturer's phantom and the ESPp 
placed together on the couch, allowing no air gap 
between them. The scan was begun in the block and 
continued into the phantom for a distance of two 
vertebrae. Results for the central vertebra were near- 
identical whichever way round the ESPp was scanned. 
As with all the DXA machines in the study, imaged 
ESPp vertebral edges were machine defined and operator 
editing was proscribed, the only allowable exceptions 
being re-definition of the intervertebral 
necessary. 
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Appendix B. Regression Models forBone Density 
The intercept represents the mean bone density in that 
centre at age 65 years, height 1.65 m and weight 70 kg. 
The values in the other columns are the percentage 
change in bone density per unit increase in that quantity. 
The 95% confidence intervals are given in parentheses. 
Units: age in years, height in cm, weight in kg, bone 
density in g/cm a. 
Appendix C. Regression Models for the Population 
Standard Deviation f Bone Density 
The intercept represents the population standard evia- 
tion in bone density in that centre at age 65 years and 
weight 70 kg. The values in the other columns are the 
percentage change in bone density per unit change in 
that quantity. The 95% confidence intervals are given in 
parentheses. 
Table B1. Spinal bone density: women 
Centre Intercept Age Age 2 Height Weight 
Aberdeen 0.947 - 0.67 % 
(0.924, 0.972) ( - 0.91%, - 0.43 %) 
Berlin t.005 --0.63% 
(0.968, 1.043) ( - 1.04%, - 0.22%) 
Budapest 0.919 --0.01% 
(0.895, 0.944) (-0.30%, 0.29%) 
Erfurt 0.943 -- 0.23% 
(0.907, 0.980) ( -  0.70%, 0,24%) 
Graz 0.934 - 0.61% 
(0.906, 0.962) (-0.92%, -0.29%) 
Harrow 1.048 - 0.80% 
(0.979, 1.123) (-1,61%, 0.02%) 
Heidelberg 1.07 t -- 0.45 % 
(1.023, 1.122) (-1.03%, 0.14%) 
Cambridge 1.054 -0.64% 
(1.026, 1.082) (-0.93%, -0.34%) 
Leuven 0.958 - 0.53% 
(0.930, 0.986) (-0.86%, -0.21%) 
Malta6 0.956 - 0.77% 
(0.918, 0.995) ( -  1.05%, -0.49%) 
Manchester 0.965 - 0.62% 
(0.906, 1.029) ( -  1.13%, -0.10%) 
Moscow 0.993 -0.28% 
(0.952, 1.036) (-0.79%, 0,23%) 
Oslo 0.933 - 0.86% 
(0.907, 0.960) ( -  1.19%, -0.53%) 
Oviedo 0.946 --0.59% 
(0.918, 0.974) (-0.86%, -0.31%) 
Piestany 0.895 - 0.17% 
(0.867, 0.923) (-0.55%, 0.22%) 
Rotterdam 0.955 - 0.42% 
(0.932, 0.979) (-0.73%, -0.10%) 
0.036% 0.16% 
(0.025%, 0.046%) (0.04%, 0.28%) 
0.41% 
(0.24%, 0.58%) 
0.49% 
(0.24%, 0.75%) 
0.92% 
(0.73%, 1.11%) 
0.64% 
(0.36%, 0.91%) 
0.51% 
(0.29%, 0.73%) 
0.71% 
(0.25%, 1.t8%) 
0.54% 
(0.18%, 0.91%) 
0.72% 
(0.53%, 0.92%) 
0.79% 
(0.58%, 1.01%) 
0.68% 
(0.36%, 1.01%) 
0.50% 
(0.03%, 0.99%) 
0.38% 
(0.10%, 0.66%) 
0.55% 
(0.31%, 0.79%) 
0.70% 
(0.47%, 0.93%) 
0.65% 
(0.40%, 0.89%) 
0.65% 
(0.45%, 0.85%) 
Variations in DXA Bone Density in Europe: The EVOS Study 
Table B2. Trochanteric bone density: women 
Centre Intercept Age Age 2 Weight 
Aberdeen 0.688 
(0.671, 0.706) 
Berlin 0.652 
(0.630, 0.674) 
Budapest 0.684 
(0.665, 0.703) 
Harrow 0.711 
(0.656, 0.770) 
Heidelberg 0.685 
(0.646, 0.725) 
Cambridge 0.652 
(0.634, 0.671) 
Leuven 0.672 
(0.649, 0.696) 
Malm6 0.652 
(0.617, 0.690) 
Manchester 0.680 
(0.646, 0.716) 
Moscow 0.649 
(0.619, 0.680) 
Oslo 0.655 
(0.612, 0.701) 
Oviedo 0.615 
(0.600, 0.631) 
Piestany 0.638 
(0.609, 0.669) 
Rotterdam 0.669 
(0.652, 0.686) 
- 0.62% 
(-0.71%, -0.52%) 
0.023% 
( 0.001%, 0.046%) 
0.068% 
( 0.034%, 0.101%) 
0.006% 
(-0.021%, 0.033%) 
- -  0.008% 
(--0.090%, 0.074%) 
0.027% 
(--0.046%, 0.100%) 
0.027% 
--0.004%, 0.058%) 
--0.014% 
--0.049%, 0.021%) 
0.046% 
0.018%, 0.075%) 
0.003% 
-0.024%, 0.030%) 
0.007% 
(-0.055%, 0.069%) 
0.044% 
(-0.071%, 0.080%) 
0.013% 
(-0.037%, 0.011%) 
0.091% 
( 0.027%, 0.155%) 
0.008% 
(--0.016%, 0.032%) 
0.79% 
(0.65%, 0.94%) 
0.39% 
(0.22%, 0.57%) 
0.90% 
(0.71%, 1.09%) 
0.80% 
(0.42%, t.19%) 
0.71% 
(0.38%, 1.04%) 
0.62% 
(0.47%, 0.78%) 
0.90% 
(0.69%, 1.12%) 
1.01% 
(0.65%, 1.37%) 
0.71% 
(0.36%, 1.07%) 
0.40% 
(0.17%, 0.62%) 
0.93% 
(0.52%, 1.34%) 
0.63% 
(0.46%, 0.80%) 
0.39% 
(0.16%, 0.63%) 
0.97% 
(0.80%, 1.15%) 
Aberdeen 0.801 
(0.787, 0.816) 
Berlin 0.788 
(0.769, 0.807) 
Budapest 0.786 
(0.773, 0.801) 
Harrow 0.804 
(0.767, 0.843) 
Heidelberg 0.781 
(0.756, 0.808) 
Cambridge 0.730 
(0.717, 0.744) 
Leuven 0.732 
(0.716, 0.749) 
Malta6 0.749 
(0.724, 0.775) 
Manchester 0.753 
(0.733, 0.773) 
Moscow 0.748 
(0.726, 0.771) 
Oslo 0.725 
(0.697, 0.754) 
Oviedo 0.723 
(0.709, 0.737) 
Piestany 0.782 
(0.761, 0.804) 
Rotterdam 0.762 
(0.747, 0.777) 
- 0.77% 0.023% 0.57% 
(--0.85%, --0.70%) (0.016%, 0.031%) (0.52%, 0.62%) 
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Tab le  B3. Femoral neck bone density: women 
Centre Intercept Age Age 2 Weight 
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Table B4. Spinal bone density: men 
M. Lunt et al. 
Centre Intercept Age Age 2 Weight 
Aberdeen 1.074 (1.051, 1.099) 0.27% ( 0.04%, 0.50%) 
Berlin 1.082 (1.052, 1.112) 0.31% ( 0.02%, 0.61%) 
Budapest 0.986 (0.958, 1.015) 0.34% ( 0.01%, 0.69%) 
Erfurt 1.030 (0.996, 1.065) 0.06% (-0.28%, 0.40%) 
Graz 1.017 (0.990, 1.045) 0.30% ( 0.00%, 0.60%) 
Harrow 1.143 (1.067, 1.224) 0.15% (-0.57%, 0.87%) 
Heidelberg 1.147 (1.100, 1.196) 0.83% ( 0.33%, 1.34%) 
Cambridge 1.163 (t.107, 1.222) -0.49% (-1.25%, 0.27%) 
Leuven 1.029 (0.995, 1.063) -0.35% (-0.69%, -0.01%) 
Malm6 1.029 (0.989, 1.071) 0.15% (-0.18%, 0.49%) 
Manchester 1.115 (1.041, 1.193) 0.47% (--0.08%, 1.02%) 
Moscow 1.112 (1.065, 1.162) 0.46% (--0.12%, 1.04%) 
Oslo 0.981 (0.952, 1.011) 0.35% ( 0.00%, 0.70%) 
Oviedo 1.097 (1.068, t.127) 0.34% ( 0.04%, 0.64%) 
Piestany 1.051 (0.992, 1.113) 0.86% ( 0.12%, 1.61%) 
Rotterdam 1.047 (1.021, 1.073) 0.31% ( 0.00%, 0.61%) 
0.011% (0.000%, 0.022%) 0.52% (0.45%, 0,59%) 
Table B5. Trochanteric bone density: men 
Centre Intercept Age Weight 
Aberdeen 0.848 (0.833, 0.862) 
Berlin 0.763 (0.745, 0.781) 
Budapest 0.789 (0.773, 0.805) 
Harrow 0.782 (0.742, 0.824) 
Heidelberg 0.794 (0.769, 0.820) 
Cambridge 0.755 (0.733, 0.777) 
Leuven 0.783 (0.759, 0.808) 
Malta6 0.800 (0.771, 0.831) 
Manchester 0.802 (0.761, 0.846) 
Moscow 0.730 (0.704, 0.757) 
Oslo 0.747 (0.707, 0.789) 
Oviedo 0.738 (0.722, 0.754) 
Piestany 0.795 (0.759, 0.833) 
Rotterdam 0.767 (0.751, 0.784) 
--0.08% (--0.17%, 0.01%) 0.53% (0.47%, 0.60%) 
Table B6. Femoral neck bone density: men 
Centre Intercept Age Height Weight 
Aberdeen 0.870 (0.850, 0.891) 0.03% (-0.24%, 0.29%) 
Berlin 0.833 (0.807, 0,859) 0.07% (-0.22%, 0.36%) 
Budapest 0.857 (0.836, 0.880) --0.15% (-0.42%, 0.12%) 
Harrow 0.830 (0.768, 0.897) 0.34% (--0.37%, 1.05%) 
Heidelberg 0.867 (0.831, 0.904) -0.10% (--0.61%, 0.42%) 
Cambridge 0.781 (0.751, 0.812) 0.36% (-0.06%, 0.78%) 
Leuven 0.794 (0.763, 0.827) --0.25% (--0.34%, --0.16%) 0.39% (--0.09%, 0.87%) 
Malm6 0.788 (0.738, 0.842) 0.42% (--0.11%, 0.96%) 
Manchester 0.793 (0.740, 0.850) 0.83% ( 0.16%, 1.52%) 
Moscow 0.839 (0.802, 0.878) 0.02% (--0.56%, 0.60%) 
Oslo 0.793 (0.717, 0.877) -0.05% (--0.72%, 0.63%) 
Ovidedo 0.848 (0.829, 0.867) --0.32% (-0.67%, 0.04%) 
Piestany 0.895 (0.834, 0.960) -0.51% (-- 1.28%, 0.27%) 
Rotterdam 0.842 (0.815, 0.870) --0.43% (--0.71%, --0.15%) 
0.51% (0.43%, 0.58%) 
Variations in DXA Bone Density in Europe: The EVOS Study 
Table C1. Standard deviation of spinal bone density: women 
Centre Intercept Age 
Aberdeen 0.1674 (0.1535, 0.1825) 
Berlin 0.2135 (0.1920, 0.2375) 
Budapest 0.1450 (0.1312, 0.1603) 
Erfurt 0.1972 (0.1739, 0.2235) 
Graz 0.2094 (0.1917, 0.2286,) 
Harrow 0.1896 (0.1500, 0.2396) 
Heidelberg 0.2074 (0.1784, 0.2410) 
Cambridge 0.I948 (0.1789, 0.2120) 
Leuven 0.1752 (0.1583, 0.1938) 
Malta6 0.1479 (0.1279, 0.1711) 
Manchester 0.1771 (0.1452, 0.2160) 
Moscow 0.1889 (0.1655, 0.2155) 
Oslo 0.1685 (0.1509, 0.i882) 
Oviedo 0.1931 (0.1770, 0.2107) 
Piestany 0.1328 (0.t141, 0.1547) 
Rotterdam 0.1783 (0.1629, 0.1952) 
1.18% (0.84%, 1.52%) 
Table C2. Standard deviation of trochanteric bone density: women 
Centre Intercept Age Weight 
Aberdeen 0.1451 (0.1329, 0.1584) 
Berlin 0.1528 (0.1374, 0.1698) 
Budapest 0.t418 (0.1282, 0.t568) 
Harrow 0.1639 (0.1301, 0.2066) 
Heidelberg 0.1903 (0.1637, 0.2212) 
Cambridge 0.1592 (0.1462, 0.1733) 
Leuven 0.1739 (0.1571, 0.1925) 
Malta6 0.I673 (0.1447, 0.1934) 
Manchester 0.1329 (0.1091, 0.16t9) 
Moscow 0.1665 (0.1459, 0.1902) 
Oslo 0.1728 (0.1429, 0.2091) 
Oviedo 0.1445 (0.1324, 0.1577) 
Piestany 0.1361 (0.1167, 0.1589) 
Rotterdam 0.1585 (0.1448, 0.1736) 
0. 5% --0.44% 
(0.17%, (--0.70%, 
0.93%) -0.17%) 
Table C3, Standard deviation of femoral neck bone density: women 
Centre Intercept Weight 
Aberdeen 0.1365 (0.1250, 0.1490) 
Berlin 0.1582 (0.1425, 0.1757) 
Budapest 0.1167 (0.1056, 0.1288) 
Harrow 0.1423 (0.1129, 0.1793) 
Heidelberg 0.1544 (0.1329, 0.t795) 
Cambridge 0.1495 (0.1373, 0.1627) 
Leuven 0.1556 (0.1407, 0.1722) 
Malm6 0.1545 (0.1338, 0.1784) 
Manchester 0.0892 (0.0733, 0.1086) 
Moscow 0.1627 (0.1425, 0.1858) 
Oslo 0.1416 (0.1171, 0.1713) 
Oviedo 0.14.63 (0.1341, 0.1596) 
Piestany 0A248 (0.1069, 0.1458) 
Rotterdam 0.1470 (0.1344, 0.1608) 
-0.38% (-0.65%, -0.12%) 
Table C4. Standard deviation of spinal bone density: men 
Centre Intercept Age 
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Aberdeen 0.1636 (0.1501, 0.1783) 
BerIin 0.t732 (0.t567, 0.1914) 
Budapest 0.1555 (0.1395, 0.t734) 
Erfurt 0.1554 (0.1349, 0.1790) 
Graz 0.2055 (0.1887, 0.2237) 
Harrow 0.1984 (0.1569, 0.2507) 
Heidelberg 0.2117 (0.1851, 0.2422) 
Cambridge 0.2021 (0.1806, 0.2262) 
Leuven 0.1754 (0.1554, 0.1980) 
Malta6 0.1654 (0.1418, 0.1931) 
Manchester 0.1516 (0.1142, 0.2013) 
Moscow 0.1777 (0.1509, 0.2093) 
Oslo 0.I707 (0.1522, 0.1915) 
Oviedo 0.I928 (0.1759, 0.2113) 
Piestany 0.1423 (0.1072, 0.1888) 
Rotterdam 0.1716 (0.1567, 0.1879) 
.77% (0.41%, 1.14%) 
Table C5, Standard eviation of trochanteric bone density: men 
Centre Intercept Age 
Aberdeen 0.1339 (0.1229, 0.1460) 
Berlin 0.1568 (0.1417, 0.1734) 
Budapest 0.1250 (0.1t21, 0.1393) 
Harrow 0.1571 (0.1243, 0.1986) 
Heidelberg 0.1627 (0.1419, 0.1865) 
Cambridge 0.1753 (0.1563, 0.1965) 
Leuven 0.1776 (0.1570, 0.2010) 
Malm6 0.1696 (0.1.455, 0.1976) 
Manchester 0.I342 (0.1011, 0.1782) 
Moscow 0.1553 (0.t319, 0.1829) 
Oslo 0.1678 (0.1336, 0.2108) 
Oviedo 0.1681 (0.1533, 0.1842) 
Piestany 0.1157 (0.0872, 0.1535) 
Rotterdam 0.1608 (0.1468, 0.176i) 
.48% (0.07%, 0.89%) 
Table C6, Standard deviation of femoral neck bone density: men 
Centre Intercept Age 
Aberdeen 0.1416 (0.1299, 0.i544) 
Berlin 0.1413 (0.1277, 0.1563) 
Budapest 0.1166 (0.1046, 0.1301) 
Harrow 0.1675 (0,1325, 0.2117) 
Heidelberg 0.1782 (0.1555, 0.2041) 
Cambridge 0.1628 (0.1452 , 0.1825) 
Leuven 0.1686 (0.1490, 0.1908) 
Malta6 0.1438 (0.1234, 0.1676) 
Manchester 0.1292 (0.0973, 0.1715) 
Moscow 0.1453 (0.1234, 0.1711) 
Oslo 0.t298 (0.1033, 0,1630) 
Oviedo 0.1710 (0.1560, 0.1874) 
Piestany 0.1067 (0.0804, 0.1416) 
Rotterdam 0.1430 (0.1306, 0.1566) 
0.57% (0.17%, 0.98%) 
